Literature DB >> 27252397

Aminoglycosides: An Overview.

Kevin M Krause1, Alisa W Serio1, Timothy R Kane1, Lynn E Connolly2.   

Abstract

Aminoglycosides are natural or semisynthetic antibiotics derived from actinomycetes. They were among the first antibiotics to be introduced for routine clinical use and several examples have been approved for use in humans. They found widespread use as first-line agents in the early days of antimicrobial chemotherapy, but were eventually replaced in the 1980s with cephalosporins, carbapenems, and fluoroquinolones. Aminoglycosides synergize with a variety of other antibacterial classes, which, in combination with the continued increase in the rise of multidrug-resistant bacteria and the potential to improve the safety and efficacy of the class through optimized dosing regimens, has led to a renewed interest in these broad-spectrum and rapidly bactericidal antibacterials.
Copyright © 2016 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27252397      PMCID: PMC4888811          DOI: 10.1101/cshperspect.a027029

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  122 in total

1.  Implementation of a once-daily aminoglycoside program in a large community-teaching hospital.

Authors:  D P Nicolau; P P Belliveau; C H Nightingale; R Quintiliani; C D Freeman
Journal:  Hosp Pharm       Date:  1995-08

2.  Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012.

Authors:  Helio S Sader; David J Farrell; Robert K Flamm; Ronald N Jones
Journal:  Int J Antimicrob Agents       Date:  2014-02-07       Impact factor: 5.283

3.  Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability.

Authors:  S Westbrock-Wadman; D R Sherman; M J Hickey; S N Coulter; Y Q Zhu; P Warrener; L Y Nguyen; R M Shawar; K R Folger; C K Stover
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

4.  Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site.

Authors:  Beatriz Llano-Sotelo; Eduardo F Azucena; Lakshmi P Kotra; Shahriar Mobashery; Christine S Chow
Journal:  Chem Biol       Date:  2002-04

5.  Aminoglycoside 2'-N-acetyltransferase genes are universally present in mycobacteria: characterization of the aac(2')-Ic gene from Mycobacterium tuberculosis and the aac(2')-Id gene from Mycobacterium smegmatis.

Authors:  J A Aínsa; E Pérez; V Pelicic; F X Berthet; B Gicquel; C Martín
Journal:  Mol Microbiol       Date:  1997-04       Impact factor: 3.501

6.  Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia.

Authors:  Helio S Sader; Paul R Rhomberg; David J Farrell; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

7.  Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa.

Authors:  Keiko Yokoyama; Yohei Doi; Kunikazu Yamane; Hiroshi Kurokawa; Naohiro Shibata; Keigo Shibayama; Tetsuya Yagi; Haru Kato; Yoshichika Arakawa
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

8.  Once versus thrice daily gentamicin in patients with serious infections.

Authors:  J M Prins; H R Büller; E J Kuijper; R A Tange; P Speelman
Journal:  Lancet       Date:  1993-02-06       Impact factor: 79.321

Review 9.  Plasmid-mediated quinolone resistance: a multifaceted threat.

Authors:  Jacob Strahilevitz; George A Jacoby; David C Hooper; Ari Robicsek
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

10.  Global spread of multiple aminoglycoside resistance genes.

Authors:  Kunikazu Yamane; Jun-ichi Wachino; Yohei Doi; Hiroshi Kurokawa; Yoshichika Arakawa
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

View more
  146 in total

1.  Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment.

Authors:  Hyejeong Hong; Kelly E Dooley; Laura E Starbird; Howard W Francis; Jason E Farley
Journal:  Arch Toxicol       Date:  2019-04-08       Impact factor: 5.153

2.  Exploiting evolutionary trade-offs for posttreatment management of drug-resistant populations.

Authors:  Sergey V Melnikov; David L Stevens; Xian Fu; Hui Si Kwok; Jin-Tao Zhang; Yue Shen; Jeffery Sabina; Kevin Lee; Harry Lee; Dieter Söll
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-13       Impact factor: 11.205

Review 3.  Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.

Authors:  Yu-Xuan Ma; Chen-Yu Wang; Yuan-Yuan Li; Jing Li; Qian-Qian Wan; Ji-Hua Chen; Franklin R Tay; Li-Na Niu
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

4.  Post-stress bacterial cell death mediated by reactive oxygen species.

Authors:  Yuzhi Hong; Jie Zeng; Xiuhong Wang; Karl Drlica; Xilin Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-04       Impact factor: 11.205

5.  Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose.

Authors:  H Hong; D W Dowdy; K E Dooley; H W Francis; C Budhathoki; H-R Han; J E Farley
Journal:  Int J Tuberc Lung Dis       Date:  2020-01-01       Impact factor: 2.373

6.  A robust LC-MS/MS method for amikacin: application to cellular uptake and pharmacokinetic studies.

Authors:  Katrina Chan; Weiqun Wang; Kimberly R Ledesma; Taijun Yin; Vincent H Tam
Journal:  Bioanalysis       Date:  2020-04-28       Impact factor: 2.681

Review 7.  Small-Molecule Acetylation by GCN5-Related N-Acetyltransferases in Bacteria.

Authors:  Rachel M Burckhardt; Jorge C Escalante-Semerena
Journal:  Microbiol Mol Biol Rev       Date:  2020-04-15       Impact factor: 11.056

8.  Fecal cultivable aerobic microbiota of dairy cows and calves acting as reservoir of clinically relevant antimicrobial resistance genes.

Authors:  João Pedro Rueda Furlan; Lucas David Rodrigues Dos Santos; Micaela Santana Ramos; Inara Fernanda Lage Gallo; Eliana Guedes Stehling
Journal:  Braz J Microbiol       Date:  2020-04-03       Impact factor: 2.476

9.  Structural analysis of a novel substrate-free form of the aminoglycoside 6'-N-acetyltransferase from Enterococcus faecium.

Authors:  Hyunseok Jang; Sunghark Kwon; Chang Sook Jeong; Chang Woo Lee; Jisub Hwang; Kyoung Ho Jung; Jun Hyuck Lee; Hyun Ho Park
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-07-28       Impact factor: 1.056

10.  Membrane voltage dysregulation driven by metabolic dysfunction underlies bactericidal activity of aminoglycosides.

Authors:  Giancarlo Noe Bruni; Joel M Kralj
Journal:  Elife       Date:  2020-08-04       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.